Related Experiment Video

Updated: May 21, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
09:59

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy

Published on: May 3, 2013

Cotargeting stress-activated Hsp27 and autophagy as a combinatorial strategy to amplify endoplasmic reticular stress

Masafumi Kumano1, Junya Furukawa, Masaki Shiota

  • 1The Vancouver Prostate Centre and Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

Molecular Cancer Therapeutics
|June 8, 2012
PubMed

Insights

Heat shock protein 27 (Hsp27) promotes cancer treatment resistance by inhibiting apoptosis. Blocking Hsp27 and autophagy simultaneously enhances cancer cell death and delays tumor growth, offering a novel therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • Heat shock protein 27 (Hsp27) is a chaperone protein implicated in cancer treatment resistance.
  • Hsp27 inhibits apoptosis and confers resistance to chemotherapy and hormone therapy in various cancers.
  • The precise mechanisms by which Hsp27 promotes treatment resistance remain incompletely understood.

Purpose of the Study:

  • To investigate the role of Hsp27 in protecting prostate cancer cells against proteotoxic stress.
  • To elucidate the mechanisms underlying Hsp27-mediated treatment resistance, focusing on apoptosis and autophagy.
  • To evaluate the therapeutic potential of cotargeting Hsp27 and autophagy in prostate cancer.

Main Methods:

  • Silencing of Hsp27 using small interfering RNA (siRNA) and antisense oligonucleotide (OGX-427).
  • Assessment of apoptosis and autophagy induction following Hsp27 suppression.
  • Evaluation of endoplasmic reticulum (ER) stress and proteasome activity.
  • In vivo studies using PC-3 prostate tumor xenografts treated with OGX-427 and chloroquine.

Main Results:

  • Hsp27 silencing induced apoptosis and autophagy in prostate cancer cells by reducing proteasome activity and increasing ER stress.
  • Autophagy activation conferred protection against ER stress-induced cell death.
  • Inhibition of autophagy enhanced cell death following Hsp27 silencing.
  • Combined treatment with OGX-427 and chloroquine (autophagy inhibitor) significantly delayed tumor growth in vivo.

Conclusions:

  • Autophagy acts as a cytoprotective adaptive pathway activated by Hsp27 silencing-induced disruption of protein homeostasis and ER stress.
  • Cotargeting Hsp27 and autophagy represents a promising therapeutic strategy to overcome treatment resistance in prostate cancer.
  • Blocking adaptive survival pathways alongside direct cancer cell targeting may improve treatment outcomes.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...